A randomized Phase III trial of comparing two dose-fractionations stereotactic body radiotherapy (SBRT) for medically inoperable Stage IA non-small cell lung cancer or small lung lesions clinically diagnosed as primary lung cancer: Japan Clinical Oncology Group Study JCOG1408 (J-SBRT trial)

Phase Iii Trial ◽

Oncology Group Study ◽

Stage Ia

A randomized phase III study of cisplatin (CDDP), etoposide (ETOP) and irinotecan versus topotecan as second-line chemotherapy in patients with sensitive relapsed small-cell lung cancer (SCLC): Japan Clinical Oncology Group study JCOG0605

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.7504 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 7504-7504

Author(s):

Koichi Goto ◽

Yuichiro Ohe ◽

Takashi Seto ◽

Toshiaki Takahashi ◽

Kazuhiko Nakagawa ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Second Line ◽

Oncology Group ◽

Small Cell Lung ◽

Oncology Group Study ◽

Phase Iii Study ◽

Line Chemotherapy

4001 ORAL Standard Thoracic Radiotherapy With or Without Concurrent Daily Low-dose Carboplatin in Elderly Patients With Locally Advanced Non-small Cell Lung Cancer – a Phase III Trial of the Japan Clinical Oncology Group (JCOG0301)

European Journal of Cancer ◽

10.1016/s0959-8049(11)71244-8 ◽

2011 ◽

Vol 47 ◽

pp. S273 ◽

Cited By ~ 1

Author(s):

S. Atagi ◽

M. Kawahara ◽

A. Yokoyama ◽

H. Okamoto ◽

N. Yamamoto ◽

...

Keyword(s):

Lung Cancer ◽

Low Dose ◽

Locally Advanced ◽

Small Cell ◽

Phase Iii ◽

Oncology Group ◽

Thoracic Radiotherapy ◽

Small Cell Lung ◽

O-155 Randomized phase III trial of carboplatin (Cb) or cisplatin (P) in combination with etoposide (E) in elderly or poor-risk patients with extensive disease small cell lung cancer (ED-SCLC): Report of a Japan Clinical Oncology Group Trial (JCOG9702)

Lung Cancer ◽

10.1016/s0169-5002(05)80289-2 ◽

2005 ◽

Vol 49 ◽

pp. S53 ◽

Cited By ~ 1

Author(s):

H. Kunitoh ◽

H. Okamoto ◽

K. Watanabe ◽

H. Kunikane ◽

A. Yokoyama ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Oncology Group ◽

Small Cell Lung ◽

Extensive Disease ◽

Phase Iii Trial ◽

Risk Patients ◽

Group Trial

A randomized phase III study of irinotecan and cisplatin (CP) versus etoposide and cisplatin (EP) in extensive-disease small-cell lung cancer (ED-SCLC): Japan Clinical Oncology Group Study (JCOG 9511)

Lung Cancer ◽

10.1016/s0169-5002(00)80095-1 ◽

2000 ◽

Vol 29 (1) ◽

pp. 30 ◽

Cited By ~ 3

Author(s):

S Negoro ◽

K Noda ◽

Y Nishiwaki ◽

M Kawahara ◽

T Tamura ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Oncology Group ◽

Small Cell Lung ◽

Extensive Disease ◽

Oncology Group Study ◽

Phase Iii Study

Interim Analysis of a Phase III Trial Comparing Cisplatin, Gemcitabine, and Vinorelbine vs. Either Cisplatin and Gemcitabine or Cisplatin and Vinorelbine in Advanced Non–Small-Cell Lung Cancer. A Southern Italy Cooperative Oncology Group Study

Clinical Lung Cancer ◽

10.3816/clc.2000.n.003 ◽

2000 ◽

Vol 1 (3) ◽

pp. 202-207 ◽

Cited By ~ 8

Author(s):

Pasquale Comella ◽

Nicola Panza ◽

Luigi Manzione ◽

Giuseppe De Cataldis ◽

Riccardo Cioffi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Interim Analysis ◽

Southern Italy ◽

Small Cell ◽

Phase Iii ◽

Oncology Group ◽

Small Cell Lung ◽

Phase Iii Trial ◽

Oncology Group Study

87 Randomized phase III trial of mitomycin plus vindesine and cisplatin versus vinorelbine and cisplatin in stage III–IV non-small cell lung cancer: A Southern Italy Oncology Group study (G.O.I.M.)

Lung Cancer ◽

10.1016/s0169-5002(97)89366-x ◽

1997 ◽

Vol 18 ◽

pp. 25

Author(s):

V. Gebbia ◽

D. Galeta ◽

F. Riccardi ◽

C. Gridelli ◽

A. Testa ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Southern Italy ◽

Small Cell ◽

Phase Iii ◽

Oncology Group ◽

Small Cell Lung ◽

Phase Iii Trial ◽

Oncology Group Study

Phase III trial of docetaxel plus gemcitabine versus docetaxel in second-line treatment for non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG0104)

Annals of Oncology ◽

10.1093/annonc/mdn705 ◽

2009 ◽

Vol 20 (5) ◽

pp. 835-841 ◽

Cited By ~ 54

Author(s):

K. Takeda ◽

S. Negoro ◽

T. Tamura ◽

Y. Nishiwaki ◽

S. Kudoh ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Line Treatment ◽

Second Line ◽

Oncology Group ◽

Small Cell Lung ◽

Phase Iii Trial ◽

Group Trial

Standard Thoracic Radiotherapy With or Without Concurrent Daily Low-dose Carboplatin in Elderly Patients with Locally Advanced Non-small Cell Lung Cancer: a Phase III Trial of the Japan Clinical Oncology Group (JCOG9812)

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyi060 ◽

2005 ◽

Vol 35 (4) ◽

pp. 195-201 ◽

Cited By ~ 48

Author(s):

Shinji Atagi ◽

Masaaki Kawahara ◽

Tomohide Tamura ◽

Kazumasa Noda ◽

Koshiro Watanabe ◽

...

Keyword(s):

Lung Cancer ◽

Low Dose ◽

Locally Advanced ◽

Small Cell ◽

Phase Iii ◽

Oncology Group ◽

Thoracic Radiotherapy ◽

Small Cell Lung ◽

Standard Thoracic Radiotherapy with or without Concurrent Daily Low-Dose Carboplatin in Elderly Patients with Locally Advanced Non-Small Cell Lung Cancer: A Phase III Trial of the Japan Clinical Oncology Group (JCOG0301)

Annals of Oncology ◽

10.1016/s0923-7534(20)32002-0 ◽

2012 ◽

Vol 23 ◽

pp. xi31

Author(s):

T. Shukuya ◽

N. Yamamoto ◽

S. Atagi ◽

M. Kawahara ◽

A. Yokoyama ◽

...

Keyword(s):

Lung Cancer ◽

Low Dose ◽

Locally Advanced ◽

Small Cell ◽

Phase Iii ◽

Oncology Group ◽

Thoracic Radiotherapy ◽

Small Cell Lung ◽

Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small-cell lung cancer: Results from a British Thoracic Oncology Group randomised phase III trial

European Journal of Cancer ◽

10.1016/j.ejca.2017.05.037 ◽

2017 ◽

Vol 83 ◽

pp. 302-312 ◽

Cited By ~ 8

Author(s):

David Ferry ◽

Lucinda Billingham ◽

Hugh Jarrett ◽

David Dunlop ◽

Penella J. Woll ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Oncology Group ◽

Small Cell Lung ◽